<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><meta name="exporter-version" content="Evernote Mac 7.14 (458244)"/><meta name="author" content="taylor.arhar@gmail.com"/><meta name="created" content="2019-01-16 22:44:58 +0000"/><meta name="source" content="desktop.mac"/><meta name="updated" content="2019-01-16 22:48:40 +0000"/><meta name="application-data:corenote-localUUID" content="6231C5A7-F8A5-42C5-877C-37B7DD4C3201"/><meta name="application-data:corenote-hostUUID" content="8989A03E-2828-4234-ABD4-8098C05925B9"/><title>January 13, 2019</title></head><body><div>Transformation of EB3 plasmid into Nova Blue and Rosetta competent cells:</div><div>- GOALS: transform into (1) Nova Blue cells to propagate EB3 pMCSG7 plasmid for future sequencing/use and (2) Rosetta cells to troubleshoot EB3 expression</div><div>- to 1 aliquot of Nova Blue cells, added 0.5uL of EB3 pMCSG7 plasmid; to 1 aliquot of Rosetta cells, added ~0.5uL (perhaps less) of EB3 pMCSG7 plasmid</div><div>- incubated on ice 5 min, heat shock 42C 45 sec, recovered on ice 2 min, added 1mL LB and allowed to incubate at 37C, 250RPM for 20 min</div><div>- for each transformation mixture, 50uL was plated onto prewarmed amp plates and allowed to incubate at 37C overnight</div><div><br/></div></body></html>
